Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...

Please purchase a subscription to read our premium content. If you have a subscription, please log in or sign up for an account on our website to continue.

Pumice stones spewed from an undersea volcano that have fouled coasts in Okinawa Prefecture have apparently made a U-turn and could reach the Izu island chain within days, a research institute’s ...

The pumice disaster should be used as an opportunity to assess and improve the nation’s preparedness for possible consequences of a massive volcanic eruption. --The Asahi Shimbun, Nov. 2 Related ...